Jagsonpal Pharmaceuticals
IPO- Website
- jagsonpal.com
- Last Round
- Private EquityFeb 2022
- Rounds
- 1
- Type
- Public
About
Jagsonpal Pharmaceuticals is a Biotech company. Its most recent funding was a Private Equity round in Feb 2022. Investors include Convergent Finance.
Funding History
Feb 2022
Investors
Similar Companies
AsymchemIPO
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Abogen Biosciences
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Eikon TherapeuticsIPO
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Hayward, United States201–500Artificial Intelligence, Biotech
Series DTotal funding$1.1BFeb 2025
Xaira Therapeutics
Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intellig...
South San Francisco, United States51–200Artificial Intelligence, Biotech
Series ATotal funding$1.0BApr 2024
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/jagsonpal-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/jagsonpal-pharmaceuticals" alt="Jagsonpal Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>